Tight regulation of the Epstein-Barr virus setpoint: Interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection

Clinical Infectious Diseases

Volumn 46, Issue 2, 2008, Pages 313-316

  Piriou, Erwan ^a,b,c   Van Dort, Karel ^a   Otto, Sigrid ^a,d   Van Oers, Marinus H J ^a   Van Baarle, Debbie ^a,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; B LYMPHOCYTE; DNA VIRUS; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEROCONVERSION; VIRUS LOAD;

B-LYMPHOCYTES; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HIV; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; VIRAL LOAD;

EID: 39449114013     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/524079     Document Type: Article

References (17)

1. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Lyon, France, 17-24 June 1997. IARC Monogr Eval Carcinog Risks Hum 1997; 70:1-492.
2. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, eds. Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:2575-628.
3. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 1997; 15:405-31.
4. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity 1998; 9:395-404.
5. Van Esser JWJ, Van der Holt B, Meijer E, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T cell-depleted SCT. Blood 2001; 98:972-8.
6. Stevens SJC, Verschuuren EAM, Pronk I, et al. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of post-transplant lymphoproliferative disease in high-risk patients. Blood 2001; 97:1165-71.
7. De Milito A. B lymphocyte dysfunctions in HIV infection. Curr HIV Res 2004; 2:11-21.
8. Stevens SJ, Blank BS, Smits PH, Meenhorst PL, Middeldorp JM. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology. AIDS 2002; 16:993-1001.
9. van Baarle D, Wolthers KC, Hovenkamp E, et al. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. J Infect Dis 2002; 186:405-9.
10. Piriou E, van Dort K, Nanlohy NM, Miedema F, Van Oers MHJ, van Baarle D. Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma. J Immunol 2004; 172:6931-7.
11. Khan G, Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA. Is EBV persistence in vivo a model for B cell homeostasis? Immunity 1996; 5:173-9.
12. + T cells after HIV treatment with highly active antiretroviral therapy. J Immunol 2005; 175:2010-7.
13. Hazenberg MD, Otto SA, van Benthem BH, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003; 17:1881-8.
14. + T helper cell depletion occurs. J Clin Invest 1988; 82:1908-14.
15. Wolthers KC, Otto SA, Lens SMA, Van Lier RAW, Miedema F, Meyaard L. Functional B cell abnormalities in HIV type 1 infection: role of CD40L and CD70. AIDS Res Hum Retroviruses 1997; 13:1023-9.
16. Laichalk LL, Thorley-Lawson DA. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 2005; 79:1296-307.
17. Chene A, Donati D, Guerreiro-Cacais AO, et al. A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog 2007; 3:e80.